| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/23/2002 | CA2428519A1 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | CA2427900A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 05/23/2002 | CA2427296A1 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 05/23/2002 | CA2426089A1 Bombesin receptor antagonists |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206553A2 Isomerase proteins |
| 05/22/2002 | EP1206543A2 Membrane associated proteins |
| 05/22/2002 | EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206480A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 05/22/2002 | EP1206478A1 Antisense modulation of mekk5 expression |
| 05/22/2002 | EP1206474A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 05/22/2002 | EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | EP1206472A1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
| 05/22/2002 | EP1206467A1 N-heterocyclic derivatives as nos inhibitors |
| 05/22/2002 | EP1206458A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 05/22/2002 | EP1206455A1 ALPHAvBETA3 INTEGRIN INHIBITORS |
| 05/22/2002 | EP1206454A1 NOVEL INTEGRIN ALPHAvBETA3 INHIBITORS |
| 05/22/2002 | EP1206448A1 Novel vitamin d analogues |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP1206265A1 Src kinase inhibitor compounds |
| 05/22/2002 | EP1206262A1 Npy antagonists: spiroisoquinolinone derivatives |
| 05/22/2002 | EP1206260A1 Src kinase inhibitor compounds |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1206190A1 Vaccines for the treatment of autoimmune disease |
| 05/22/2002 | EP1182200A9 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| 05/22/2002 | EP1152776B1 Biodegradable, injectable oligomer-polymer composition |
| 05/22/2002 | EP1147107A4 Novel angiogenesis inhibitors |
| 05/22/2002 | EP0902681B1 Inhibition of selectin binding |
| 05/22/2002 | EP0894093B1 Soluble tachykinin antagonists, the preparation and use thereof |
| 05/22/2002 | EP0766676B1 Compounds for inhibiting phosphodiesterase iv |
| 05/22/2002 | EP0746329B1 Anti-inflammatory factor containing compositions, method of production, and use |
| 05/22/2002 | EP0583360B1 Compositions for the prevention and/or treatment of pathological processes |
| 05/22/2002 | CN1350539A Imidazo-containing heterocyclic compounds, their compositions and uses |
| 05/22/2002 | CN1350537A Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | CN1350536A 氨基甲酰基四氢吡啶衍生物 Carbamoyl tetrahydropyridine derivative |
| 05/22/2002 | CN1350535A Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 05/22/2002 | CN1350534A Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 05/22/2002 | CN1350530A 酰胺衍生物 Amide derivatives |
| 05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 05/22/2002 | CN1350458A Protease inhibitors |
| 05/22/2002 | CN1350455A Use of combination of vitamins for the treatment of pruritus and relating to itching and/or non-infective inflammatory disorders |
| 05/22/2002 | CN1349822A Wind-evil dispelling medicine |
| 05/22/2002 | CN1349819A Myocarditis treating Chinese medicine prepn |
| 05/22/2002 | CN1349815A Prepn of rheumatism treating medicine powder |
| 05/22/2002 | CN1085212C Rapamycin 42-oximes and hydroxylamines |
| 05/22/2002 | CN1085205C Bicyclic amino acids |
| 05/21/2002 | US6392100 Antiinflammatory agents; antiproliferative agents; immunosuppressants; viricides |
| 05/21/2002 | US6392053 Process for preparing arylacetylaminothiazoles |
| 05/21/2002 | US6392045 9-azobicyclo[3.3.1] non-2-ene derivatives as cholinergic ligands at nicotinic ACH receptors |
| 05/21/2002 | US6392039 Coupling; salt formation |
| 05/21/2002 | US6392036 Sanitizing particles in sample; obtain sample, expose to heat, monitor sample for antiseptic nature |
| 05/21/2002 | US6392020 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical compostion and a diagnostic reagent comprising the same |
| 05/21/2002 | US6391909 Anandamide inhibitors as analgesic agents |
| 05/21/2002 | US6391908 Oxime amide indole type sPLA2 inhibitors |
| 05/21/2002 | US6391906 Non-steroidal anti-inflammatory agents |
| 05/21/2002 | US6391904 Bone disorders |
| 05/21/2002 | US6391894 Myt1 kinase inhibitors |
| 05/21/2002 | US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors |
| 05/21/2002 | US6391856 Method for treatment of allergic reaction using formyl peptide |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391832 Medical emulsion for lubrication and delivery of drugs |
| 05/21/2002 | US6391616 Oidiodendron strain for the production of terpenoid lactone compounds |
| 05/21/2002 | US6391340 Dry powder pharmaceutical formulation |
| 05/21/2002 | CA2216664C New n-substituted cyclical amines, their preparation process and the pharmaceutical compositions containing them |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038726A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/16/2002 | WO2002038610A1 Process for the preparation of latent antithrombin iii |
| 05/16/2002 | WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
| 05/16/2002 | WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors |
| 05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 05/16/2002 | WO2002038548A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 05/16/2002 | WO2002038547A1 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 05/16/2002 | WO2002038541A1 Cyanopyrrolidine derivatives |
| 05/16/2002 | WO2002038266A1 Apparatus and method for producing antimicrobial silver solution |
| 05/16/2002 | WO2002038169A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | WO2002038168A2 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 05/16/2002 | WO2002038160A1 Method for the treatment of inflammation |
| 05/16/2002 | WO2002038140A2 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | WO2002038106A2 Calcilytic compounds |
| 05/16/2002 | WO2002037937A2 Acid derivatives useful as serine protease inhibitors |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002019994A3 The treatment of inflammatory disorders |
| 05/16/2002 | WO2002017892A3 Water-dispersible encapsulated sterols |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2002002090A3 Inhibitors of copper-containing amine oxidases |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001098290A3 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/16/2002 | WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001081622A8 Diagnosis of diseases associated with dna repair |
| 05/16/2002 | WO2001079843A3 Screening method for compounds |
| 05/16/2002 | WO2001076638A3 Compositions for drug delivery |
| 05/16/2002 | WO2001070663A3 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 05/16/2002 | WO2001049654A3 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 05/16/2002 | WO2001046180A3 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | US20020058839 Methods and compositions for modulating alpha adrenergic receptor activity |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058690 For therapy and prophylaxis of inflammatory disease susceptible to treatment with a non- steroidal anti-inflammatory agent |